Skip to main content
HOUSE 919119th CongressReferred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Commemorating and supporting the goals of World AIDS Day.

Last Action
12/2/2025

Actions

  • 2025-03-05Received in the Senate and Read twice and referred to the Committee on Finance.
  • 2025-03-04Motion to reconsider laid on the table Agreed to without objection.
  • 2025-03-04On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
  • 2025-03-04Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H964)
  • 2025-03-04DEBATE - The House proceeded with forty minutes of debate on H.R. 919.
  • 2025-03-04Considered under suspension of the rules. (consideration: CR H964-966)
  • 2025-03-04Mr. Smith (MO) moved to suspend the rules and pass the bill.
  • 2025-02-04Referred to the House Committee on Ways and Means.
  • 2025-02-04Introduced in House
  • 2025-02-04Introduced in House

CRS Summary

As of 2025-02-04 (00)

Chronic Disease Flexible Coverage Act

This bill provides statutory authority for guidance from the Internal Revenue Service (IRS) that expands the types of preventive care that may be offered under a high deductible health plan (HDHP) without requiring a deductible or with a deductible below the minimum threshold.

Under current law, to be considered health savings account-eligible, an HDHP must have a deductible above a certain minimum threshold amount, which is adjusted annually. However, an HDHP may cover certain types of preventive care without requiring a deductible or with a deductible below the minimum threshold. 

The IRS issued guidance expanding the types of preventive care that may be covered by an HDHP without requiring a deductible or with a deductible below the minimum threshold to include

  • angiotensin converting enzyme inhibitors for individuals with congestive heart failure, diabetes, or coronary artery disease;
  • anti-resorptive therapy for individuals with osteoporosis or osteopenia;
  • beta-blockers for individuals with congestive heart failure or coronary artery disease;
  • blood pressure monitors for individuals with hypertension;
  • inhaled corticosteroids and peak flow meters for individuals with asthma;
  • insulin and other glucose lowering agents, retinopathy screening, glucometers, and hemoglobin A1c testing for individuals with diabetes;
  • international normalized ratio testing for individuals with liver disease or bleeding disorders;
  • low-density lipoprotein testing for individuals with heart disease;
  • statins for individuals with heart disease or diabetes; and
  • selective serotonin reuptake inhibitors for individuals with depression. 

The bill provides statutory authority for the IRS's guidance. 

Cosponsors (2)

  • Jimmy Panetta (D-CA)
  • Claudia Tenney (R-NY)

Subjects

  • Health care costs and insurance
  • Health care coverage and access
  • Health promotion and preventive care
  • Income tax deductions
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.